Antagonizing the binding of HGF to HGFR also inhibited invasion in HuCC-T1, a human CC cell line, in vitro and in vivo [46] suggesting that blockade of HGFR might be a therapeutic strategy which should be the focus of further studies. This evidence concerns the gene MET and cholangiocarcinoma.